Published on
March 15, 2022
- 10:45 GMT
ViroCarb Inc. announces funding to develop a novel oral anti-COVID 19 treatment
TORONTO, ONTARIO, CANADA, March 15, 2022 /EINPresswire.com/ -- ViroCarb Inc. is pleased to announce that it is receiving advisory services and funding of up to $160,500 from the National Research Council of Canada Industrial Research Assistance Program ( …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
